Personalized medicine: Blood tests combined with genome sequencing yield breakthrough therapy

play DNA
Personalized genomic medicine has long been expected to blossom as sequencing of an individual’s human genome is nearing the $1,000 mark. In a remarkable new story, one professor, who sequenced his own genome, found that he was a high risk for Type 2 diabetes—then used blood tests to find out if he might develop the disease. Seven months into the experiment, he developed diabetes and began treatment, long before it might have been if the professor had relied on a conventional visits to the doctor.
Additional Resources:
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend